Genetics Define Biomarkers of Response to Immunotherapy
December 10, 2024
Immune checkpoint inhibitor (ICI) therapy, such as nivolumab, pembrolizumab, atezolizumab or combinations with ipilimumab, can be extremely impactful for treating…
The Immunotherapy 360 blog space features articles that encompass prominent issues related to immunotherapy. These are written with the assistance of the staff at AIM at Melanoma, AIM with Immunotherapy and health care practitioners.
If you have an idea for a future article, please reach out to us on our contact page!
